MADISON, New Jersey, September 23, 2024 – LEO Pharma Inc. announced today that the Food and Drug Administration (FDA) has accepted for filing a New Drug Application (NDA) for delgocitinib cream 20 mg/g (2%) for the treatment of adults with…Original Article
You may also like
UroGen Submits Completed UGN-102 NDA Seeking Approval...
Iterum Therapeutics Provides Update on FDA Advisory...
AbbVie Submits Biologics License Application to the...
PTC Therapeutics Announces FDA Acceptance for Filing...
Stealth BioTherapeutics Announces Positive Vote from...
U.S. Food and Drug Administration (FDA) Accepts New...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.